Development of mirror-image monobodies targeting the oncogenic BCR::ABL1 kinase
Abstract Mirror-image proteins, composed of d-amino acids, are an attractive therapeutic modality, as they exhibit high metabolic stability and lack immunogenicity. Development of mirror-image binding proteins is achieved through chemical synthesis of d-target proteins, phage display library selecti...
Saved in:
| Main Authors: | Nina Schmidt, Amit Kumar, Lukas Korf, Adrian Valentin Dinh-Fricke, Frank Abendroth, Akiko Koide, Uwe Linne, Magdalena Rakwalska-Bange, Shohei Koide, Lars-Oliver Essen, Olalla Vázquez, Oliver Hantschel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54901-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR: ABL1 signaling
by: Chiara Lebon, et al.
Published: (2024-10-01) -
Current and future of targeted therapies against BCR::ABL kinases
by: Sridhar Jayavel, et al.
Published: (2025-04-01) -
Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms
by: Linet Njue, et al.
Published: (2020-12-01) -
Association of Clinical Features and Hematological Laboratories between Ph (+)/BCR-ABL (+) Chronic Myeloid Leukemia and Other Type of Ph/BCR-ABL Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2018-03-01) -
Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
by: Benedetta Mariotti, et al.
Published: (2019-01-01)